Research and development in the pharmaceutical industry
By: Congress of the United States, Congressional Budget Office .
Contributors: United States. Congressional Budget Office.
Series: CBO study
Publisher: Congress of the United States, Congressional Budget Office
Published: 2006
Place of publication: Washington, D.C
Language: eng
Number of pages: 55
Subjects: Drugs -- Research -- Government policy -- United States; Drug development -- United States; Pharmaceutical industry -- Economic aspects
Notes: "David H. Austin prepared this report ... "-- Pref.

"October 2006."

Includes bibliographical references (p. [51]-55).

Also available via the World Wide Web.

Mode of access: Internet from the CBO web site. Address as of 10/19/06: http://www.cbo.gov/ftpdocs/76xx/doc7615/10-02-DrugR-D.pdf; current access is available via PURL.
Table of contents: title: Introduction and summary; title: Trends in R&D spending and output of new drugs; title: What does lit cost to develop new drug?; title: Does federal R&D spending stimulate or substitute for private-sector spending?; title: Has the drug industry's innovative performance declined?; title: Profitability and R&D investment in the drug industry; title: References; title: Tables; title: Figures; title: Boxes.